Stay updated on Clinical Trial of IL-2 + Nivolumab in RCC

Sign up to get notified when there's something new on the Clinical Trial of IL-2 + Nivolumab in RCC page.
Latest website image capture
Clouds background image

Latest updates to the Clinical Trial of IL-2 + Nivolumab in RCC page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added, and the broad government funding operating-status notice was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T14:22:55.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    New government funding notice banner now appears at the top of the page. The page revision tag was updated from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T10:26:25.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Glossary display is now shown and UI metadata was updated to include 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data' with a new 'Revision: v3.4.0' note. The previous items 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T05:01:19.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    A minor site revision was applied: Revision v3.3.4 was added and Revision v3.3.3 was removed.
    Difference
    0.1%
    Check dated 2026-01-14T02:32:27.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Locations sections updated to include Michigan, Minnesota, and Ohio sites, replacing the prior locations blocks. Page revision updated from v3.3.2 to v3.3.3.
    Difference
    0.4%
    Check dated 2025-12-23T10:22:00.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    Site revision label updated from v3.3.1 to v3.3.2. No changes to the study details, eligibility criteria, outcomes, or links on the page.
    Difference
    0.1%
    Check dated 2025-12-01T16:58:34.000Z thumbnail image

Stay in the know with updates to Clinical Trial of IL-2 + Nivolumab in RCC

Enter your email address, and we'll notify you when there's something new on the Clinical Trial of IL-2 + Nivolumab in RCC page.